Tokyo, Japan

Keiko Fukasawa

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Other. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keiko Fukasawa. Retrieved from https://idiyas.com/inventor/keiko-fukasawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,570 
Other
 patents

Years Active: 2025

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keiko Fukasawa: Innovator in Phosphatidic Acid Research

Introduction

Keiko Fukasawa is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the study of phosphatidic acids. His innovative work has led to the development of a novel analog that has potential physiological applications.

Latest Patents

Fukasawa holds a patent for Carbalysophosphatidic acid. This invention aims to identify a new analog of carbacyclic phosphatidic acid, which is a cyclic phosphatidic acid derivative. The patent clarifies the physiological activity of this compound, represented by a specific formula.

Career Highlights

Throughout his career, Fukasawa has worked with various organizations, contributing to advancements in his field. His research has been pivotal in understanding the complexities of phosphatidic acids and their derivatives.

Collaborations

Fukasawa has collaborated with notable individuals in his field, including Kimiko Murofushi and Mari Gotoh. These partnerships have enriched his research and expanded the impact of his work.

Conclusion

Keiko Fukasawa's contributions to the field of biochemistry, particularly through his patent on Carbalysophosphatidic acid, highlight his role as an innovator. His work continues to influence research in phosphatidic acids and their physiological implications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…